LRN Q1 2026 Earnings EPS Beat of 289 Drives Modest Stock Gains SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics COST Q1 2026 Earnings EPS Falls Short of Estimates on Margin Pressure CLBK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline